Nicardipine Hydrochloride Injection, Solution
Product Images NDC 25021-333

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 25021-333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nic06 0000 01)

Chemical Structure (Nic06 0000 01)
Chemical structure of Nicardipine Hydrochloride, illustrating its molecular framework with aromatic rings, nitro group, ester, and hydrochloride components along with the molecular formula C25H29N3O6·HCl.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Nic06 0000 02)

Package Label – Principal Display Panel – Vial Label (Nic06 0000 02)
Nicardipine Hydrochloride Injection, USP 25 mg per 10 mL (2.5 mg per mL) vial label. For intravenous use only, single-dose vial with instructions to dilute before infusion and discard unused portion. Label shows NDC 25021-333-10, manufactured by Sagent Pharmaceuticals, Schaumburg, IL, made in China, with storage instructions to keep at 20 to 25°C away from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.